Vaccine trial by Moderna shows promising early results

Vaccine trial by Moderna shows promising early results”

United States stocks surged Monday on hopes for a coronavirus vaccine that could allow the global economy to emerge from its pandemic-induced coma. The company didn't have detailed data on the rest of the 45 trial participants, but all generated at least some antibodies. He said the results indicate the vaccine has a "high probability to provide protection from COVID-19 disease in humans".

Investors cheered the initial results Monday morning, sending Moderna's stock up almost 30%. The firm's CEO Stephane Bancel said phase one is still ongoing and previewed the next steps of the trial.

A sign marks an entrance to a Moderna, Inc., building, on May 18, 2020, in Cambridge, Mass. Moderna announced May 18, 2020, that an experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers. He says questions still remain regarding general efficacy, and whether the data can be generalized for other demographics, such as older age groups.

The U.S. National Institute of Allergy and Infectious Diseases led the experiment, also called a trial. The next phase will test doses between 25 and 100 micrograms. One patient at a lower dose level experienced redness at the injection site. The company said that after two doses, all 45 trial participants had developed coronavirus antibodies. The researchers found that at two lower dose levels used in the study, levels of antibodies found after getting a second booster shot of the vaccine either equaled or exceeded the levels of antibodies found in patients who had recovered from the virus. The levels of those so-called neutralising antibodies matched the levels found in patients who had recovered after contracting the virus in the community. What's more, it's promising the antibodies the patients developed were "shown to be effective at limiting the virus's replication in the lab", he added.

Importantly, the vaccine appears to be "generally safe and well-tolerated" with no life-threatening side effects, the company said. The highest dose caused fever, muscle aches, and headaches. "We're doing our best to make it as many millions as possible".

Vaccine trial by Moderna shows promising early results

Moderna has been working closely with the National Institutes of Health since January to find a vaccine and tested the vaccine on mice before moving on to human trials in March.

"The lower the dose, the more vaccine we'll be able to make", Dr Zaks said.

There are now no approved treatments or vaccines for COVID-19. "That being said, this is a new kind of vaccine platform, and some of the safety signals may take time to be recognized".

As the Wall Street Journal reported last week, the debate is raging in the medical community about whether the risks of a human challenge trial are worth it in the case of this virus, and the World Health Organization has already published a document outlining the "ethical acceptability" of such a trial. However, the drug is considered experimental and isn't considered a safe or effective treatment for COVID-19, and needs more clinical study.

More news: Celtic declared champions as Scottish Premiership season abandoned

Like this



19 May 2020
Detroit priest uses water pistol for socially distanced holy water blessing
Parishioners have tied blue ribbons on trees at the church for each person who has died of COVID-19 in MI . MI has been hit hard by the coronavirus , with at least 4,891 deaths, behind New York, New Jersey and MA .

19 May 2020
Trump threatens permanent freeze on WHO funding in 30 days
In April, Trump said the World Health Organization was China-centric and temporarily cut funding with a review pending. US President Donald Trump has branded the global body a "puppet of China".

19 May 2020
Gretchen Whitmer Will Let Some Retail Businesses Reopen Friday in MI
The recommended social distancing practices, such as maintaining six feet of separation between strangers, must be maintained. All businesses that will reopen must adopt the safety measures outlined in the Executive Order 2020-91.

19 May 2020
Brian Austin Green Shares Butterfly Post Amid Alleged Megan Fox Split
Meanwhile, the 46-year-old Beckinsale has now moved on to 22-year-old singer Goody Grace because why the hell not? And apparently, just being close friends with Pete Davidson , means some of that luck rubs off on a guy.

19 May 2020
Lack of immunity makes China vulnerable to second wave of virus infection
As everybody knows, the birthplace of the novel CoronaVirus is Wuhan of Chinese Province in late December 2019. Jilin is the second largest city of Jilin province, which borders North Korea and Russian Federation .

19 May 2020
Uber Cuts 3000 More Jobs As Pandemic Squeezes Ride-Hailing
The offices being shuttered include one of Uber's downtown San Francisco hubs, which was home to more than 500 employees. Uber lost $2.9 billion in the first quarter as the coronavirus pandemic decimated its overseas investments.

19 May 2020
Pompeo denies inspector general fired as payback for investigation
The U.S. said at the time the weapons were needed to deter what it called "the malign influence" of Iran throughout the Middle East.

19 May 2020
Chris Paul And Trae Young Headline First-Ever NBA HORSE Challenge
From there, the victor from each group advances to the championship round. ESPN will broadcast all games, starting with the opening round on Sunday.

19 May 2020
Kyrgios tells Murray: 'You're Better Than Djokovic'
We all love you. "Team World, that is what we are all about man, if you ( Murray ) came over to Team World we would win". He was trying to dodge it, you were on it like a light'. "I like to get up and about with the boys", Kyrgios said.

19 May 2020
Fed’s Powell says full economic recovery may require coronavirus vaccine
On Sunday night, Powell said the Fed's programs were essentially unlimited, helping to spark a stock market rally Monday. It could stretch through the end of next year. "We really don't know".